[
    {
        "Category": "Geography",
        "Field Name": "Cluster",
        "Description": "Depends on the business requirements for identifying priorities for CHC, GEM, EU, DB 1/2/3/4 For example, priority 1 countries for Diabetes will be in EU DB1",
        "Example": "CHC"
    },
    {
        "Category": "Geography",
        "Field Name": "Region",
        "Description": "Region classification as per Sanofi definition",
        "Example": "Europe"
    },
    {
        "Category": "Geography",
        "Field Name": "Zone",
        "Description": "Business geographic segmentation as per Sanofi definition - sub-regions",
        "Example": "NOBA"
    },
    {
        "Category": "Geography",
        "Field Name": "MCO",
        "Description": "Multi countries organization - group of countries based on BU requirements",
        "Example": "Benelux"
    },
    {
        "Category": "Geography",
        "Field Name": "Country",
        "Description": "Country name within the data",
        "Example": "Belgium"
    },
    {
        "Category": "Geography",
        "Field Name": "Channel",
        "Description": "Last intermediary between Manufacturer and the final user: where the patient get the product, e.g.; Retail, Hospital",
        "Example": "Retail"
    },
    {
        "Category": "Market",
        "Field Name": "Market Categories ",
        "Description": "Sanofi Market description: 6 levels of categories (Category 0 is the more granular) , detailed in 'Market Definition' section",
        "Example": "DCV (Category 5)",
        "Note": "For CHC, we have only 2 levels : Master category & sub category"
    },
    {
        "Category": "Market",
        "Field Name": "Mode of Delivery",
        "Description": "Split into the three existing types of mode of delivery which are disposables, cartridges and vials for all Diabetes injectable products (GLP-1, FRC, Rapid, Premix, Basal)",
        "Example": "Disposable",
        "Note": "Only available for Europe Market"
    },
    {
        "Category": "Market",
        "Field Name": "Segment",
        "Description": "Level of granularity specific to a category according to business needs",
        "Example": "Human"
    },
    {
        "Category": "Product",
        "Field Name": "Corporation group 2",
        "Description": "Split on specific Multinational Corporations (MNC) or others Multinational Corporations (Others MNCs) For example, at a global level, the list of MNCs includes mainly Astrazeneca, Bristol-Myers SQB, Glaxosmithkline, Johnson & Johnson, Lilly, Merck & Co, Merck KGAA, Novartis, Pfizer, Sanofi At a global level, the list of Others MNCs includes mainly Aspen, Bayer, Mylan, Takeda, etc."
    },
    {
        "Category": "Product",
        "Field Name": "Corporation group 1 ",
        "Description": "International corporations cleaned, mapped and regrouped For example, the local corporation called 'Genzyme corp' will be harmonized at an international leval as 'Sanofi'",
        "Example": "Sanofi"
    },
    {
        "Category": "Product",
        "Field Name": "Product Group 3 ",
        "Description": "Product grouping defined by the name of the molecule",
        "Example": "GLARGINE",
        "Note": "For CHC, another segmentation is applied : product family and product name"
    },
    {
        "Category": "Product",
        "Field Name": "Product Group 2",
        "Description": "Product grouping defined by the name of the family brand or the name of the product or the generic",
        "Example": "Sanofi Glargine"
    },
    {
        "Category": "Product",
        "Field Name": "Product Group 1 ",
        "Description": "Product grouping defined by the name of the product or the generic. This dimension can be used if products have different names in the countries or if several products exist",
        "Example": "LANTUS"
    },
    {
        "Category": "Product",
        "Field Name": "RX / OTC",
        "Description": "Split between RX and OTC",
        "Example": "RX"
    },
    {
        "Category": "Product",
        "Field Name": "PI status",
        "Description": "Classification according to the IMS definition of a parallel Import/non parallel import (PI or no PI status) products. For example, Germany imports drugs from others countries, then this products will be marked as PI",
        "Example": "PI"
    }
]